Increasing unusual call option volume: RGLS PAGS ASTL JNPR EWY NVTS Jun 25, 2025 04:57AM
Regulus Therapeutics (RGLS) Tops Q1 EPS by 10c May 8, 2025 04:39PM
Leerink Partners Downgrades Regulus Therapeutics (RGLS) to Market Perform Apr 30, 2025 11:19PM
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Regulus Therapeutics Inc. Buyout Apr 30, 2025 02:45PM
Regulus Therapeutics (RGLS) to be Acquired by Novartis (NVS) for $7 Per Share Apr 30, 2025 07:01AM


Mar 27, 2025 03:38PM Wells Fargo Upgrades Regulus Therapeutics (RGLS) to Overweight
Mar 27, 2025 08:28AM Regulus Therapeutics (RGLS) Announces Successful Completion of its Phase 1b MAD Clinical Trial of Farabursen (RGLS8429) for the Treatment of ADPKD
Mar 14, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Regulus Therapeutics (RGLS)
Jan 29, 2025 07:03AM Regulus Therapeutics (RGLS) Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen
Nov 29, 2024 07:43AM Jones Trading Reiterates Buy Rating on Regulus Therapeutics (RGLS)
Nov 7, 2024 05:13PM Regulus Therapeutics (RGLS) Misses Q3 EPS by 4c
Oct 9, 2024 07:22AM H.C. Wainwright Reiterates Buy Rating on Regulus Therapeutics (RGLS)
Oct 9, 2024 06:29AM Canaccord Genuity Reiterates Buy Rating on Regulus Therapeutics (RGLS)
Aug 8, 2024 05:03PM Regulus Therapeutics (RGLS) Misses Q2 EPS by 5c
Jul 16, 2024 10:54AM H.C. Wainwright Reiterates Buy Rating on Regulus Therapeutics (RGLS)
Jun 25, 2024 06:41AM Regulus Therapeutics (RGLS) PT Raised to $10 at H.C. Wainwright
Jun 24, 2024 02:07PM Jones Trading Reiterates Buy Rating on Regulus Therapeutics (RGLS)
Jun 24, 2024 07:02AM Regulus Therapeutics (RGLS) Announces Positive Topline Data from Third Cohort in Phase 1b Trial of RGLS8429